{"content": {"tumorNameEn": "Glioblastoma,IDH-wildtype", "NameInCN": ["\u80f6\u8d28\u6bcd\u7ec6\u80de\u7624,IDH\u91ce\u751f\u578b"], "nameAlsoEn": ["glioblastoma multiforme", "spongioblastoma"], "nameAlsoCn": ["\u591a\u5f62\u6027\u80f6\u6bcd\u7ec6\u80de\u7624", "\u6210\u80f6\u8d28\u7ec6\u80de\u7624", "\u6076\u6027\u80f6\u8d28\u7624"], "MeshCode": ["D005909"], "ICD_10Code": ["C71.9"], "ICD_OCode": ["9440/3"], "MeshThematicWord": ["Glioblastoma"], "ICDThematicWord": ["Malignant neoplasm of brain-Brain, unspecified"], "definitionCn": ["\u6700\u6076\u6027\u7684\u661f\u5f62\u7ec6\u80de\u7624\uff08WHO IV\u7ea7\uff09\u3002 \u5b83\u7531\u4f4e\u5206\u5316\u7684\u80bf\u7624\u661f\u5f62\u80f6\u8d28\u7ec6\u80de\u7ec4\u6210,\u5176\u7279\u5f81\u5728\u4e8e\u5b58\u5728\u7ec6\u80de\u591a\u6001\u6027,\u6838\u5f02\u578b\u6027,\u6709\u4e1d\u5206\u88c2\u6d3b\u6027,\u8840\u7ba1\u8840\u6813\u5f62\u6210,\u5fae\u8840\u7ba1\u589e\u751f\u548c\u574f\u6b7b\u3002 \u5b83\u901a\u5e38\u5f71\u54cd\u6210\u4eba,\u5e76\u4e14\u4f18\u5148\u4f4d\u4e8e\u5927\u8111\u534a\u7403\u3002 \u5b83\u53ef\u80fd\u7531\u5f25\u6f2b\u6027\u661f\u5f62\u7ec6\u80de\u7624WHO II\u7ea7\u6216\u95f4\u53d8\u6027\u661f\u5f62\u7ec6\u80de\u7624\uff08\u7ee7\u53d1\u6027\u80f6\u8d28\u6bcd\u7ec6\u80de\u7624,IDH\u7a81\u53d8\u578b\uff09\u53d1\u5c55\u800c\u6765,\u4f46\u66f4\u5e38\u89c1\u7684\u662f,\u5b83\u5728\u77ed\u6682\u7684\u4e34\u5e8a\u75c5\u53f2\u540e\u4ece\u5934\u8868\u73b0,\u6ca1\u6709\u6076\u6027\u524d\u4f53\u75c5\u53d8\u7684\u8bc1\u636e\uff08\u539f\u53d1\u80f6\u8d28\u6bcd\u7ec6\u80de\u7624,IDH-\u91ce\u751f\u578b\uff09"], "definitionEn": [" The most malignant astrocytic tumor (WHO grade IV). It is composed of poorly differentiated neoplastic astrocytes and it is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. It may develop from diffuse astrocytoma WHO grade II or anaplastic astrocytoma (secondary glioblastoma, IDH-mutant), but more frequently, it manifests after a short clinical history de novo, without evidence of a less malignant precursor lesion (primary glioblastoma, IDH- wildtype)"], "isDefinedBy": ["NCI"], "OccurrenceRate": ["\u6682\u7f3a"], "hasHighOccurrenceRateIn": [["middle-aged", "\u4e2d\u5e74"], ["old", "\u8001\u5e74"]], "hasFindingSite": [["corpusCallosum", "\u80fc\u80dd\u4f53"], ["meningealLayers", "\u8111\u819c\u5c42"]], "hasSymptoms": [["Seizure", "\u766b\u75eb"], ["OralHaemorrhage", "\u53e3\u8154\u51fa\u8840"], ["IncreasedIntracranialPressure", "\u9885\u5185\u538b\u5347\u9ad8"], ["NeurologicalDeficit", "\u795e\u7ecf\u53d7\u635f"]], "Pathogeny": ["The cause of most cases is unclear.About 5% develop from another type brain tumor known as a low-grade astrocytoma.Other associations include exposure to smoking, pesticides, and working in petroleum refining or rubber manufacturing.Glioblastoma has been associated with the viruses SV40,HHV-6,and cytomegalovirus."], "isDiagnosedBy": [["CT", "\u7535\u5b50\u8ba1\u7b97\u673a\u65ad\u5c42\u626b\u63cf"], ["MRI", "\u6838\u78c1\u5171\u632f\u68c0\u67e5"], ["PET", "\u6b63\u7535\u5b50\u53d1\u5c04\u578b\u8ba1\u7b97\u673a\u65ad\u5c42\u663e\u50cf"]], "DifferentialDiagnosis": ["General imaging differential considerations include:\ncerebral metastasis:\nmay look identical\nboth may appear multifocal\nmetastases usually are centred on grey-white matter junction and spare the overlying cortex\nrCBV in the 'oedema' will be reduced \nprimary CNS lymphoma:\nshould be considered especially in patients with AIDS, as in this setting central necrosis is more common\notherwise usually homogeneously enhancing \ncerebral abscess:\ncentral restricted diffusion is helpful, however, if GBM is hemorrhagic then assessment may be difficult \npresence of smooth and complete SWI low-intensity rim \npresence of dual rim sign \nanaplastic astrocytoma:\nshould not have central necrosis\nconsider histology sampling bias \ntumefactive demyelination:\ncan appear similar\noften has an open ring pattern of enhancement\nusually younger patients\nsubacute cerebral infarction:\nhistory is essential in suggesting the diagNOSis\nshould not have elevated choline\nshould not have elevated rCBV\ncerebral toxoplasmosis:\nespecially in patients with AIDS"], "associatedTumours": [{"id": "tumor_child_10", "name": ["AnaplasticAstrocytoma,IDH-mutant", "\u95f4\u53d8\u6027\u661f\u5f62\u7ec6\u80de\u7624,IDH\u7a81\u53d8\u578b"], "type": 0}, {"id": "tumor_child_11", "name": ["AnaplasticAstrocytoma,IDH-wildtype", "\u95f4\u53d8\u6027\u661f\u5f62\u7ec6\u80de\u7624,IDH\u91ce\u751f\u578b"], "type": 0}, {"id": "tumor_child_12", "name": ["AnaplasticAstrocytoma,NOS", "\u95f4\u53d8\u6027\u661f\u5f62\u7ec6\u80de\u7624,NOS"], "type": 0}, {"id": "tumor_child_100", "name": ["Haemangioblastoma", "\u8840\u7ba1\u6bcd\u7ec6\u80de\u7624"], "type": 0}, {"id": "tumor_child_64", "name": ["AIDS-relatedDiffuseLargeB-cellLymphoma", "AIDS\u76f8\u5173\u5f25\u6f2b\u5927B\u7ec6\u80de\u6dcb\u5df4\u7624"], "type": 0}, {"id": "tumor_child_65", "name": ["EBV-positiveDiffuseLargeB-cellLymphoma,NOS", "EB\u75c5\u6bd2\u9633\u6027\u5f25\u6f2b\u5927B\u7ec6\u80de\u6dcb\u5df4\u7624,NOS"], "type": 0}, {"id": "tumor_child_66", "name": ["LymphomatoidGranulomatosis", "\u6dcb\u5df4\u7624\u6837\u8089\u82bd\u80bf\u75c5"], "type": 0}, {"id": "tumor_child_67", "name": ["IntravascularLargeB-cellLymphoma", "\u8840\u7ba1\u5185\u5927B\u7ec6\u80de\u6dcb\u5df4\u7624"], "type": 0}, {"id": "tumor_child_68", "name": ["MALTLymphomaOfTheDura", "\u786c\u8111\u819c\u9ecf\u819c\u76f8\u5173\u6dcb\u5df4\u7ec4\u7ec7\u6dcb\u5df4\u7624"], "type": 0}, {"id": "tumor_child_21", "name": ["Gliosarcoma", "\u80f6\u8d28\u8089\u7624"], "type": 0}, {"id": "tumor_child_42", "name": ["Ependymoma", "\u5ba4\u7ba1\u819c\u7624"], "type": 0}], "OtherAssociatedIllness": ["cerebral metastasis;cerebral abscess;  tumefactive demyelination; subacute cerebral infarction; cerebral toxoplasmosis"], "CTImageDescription": ["irregular thick margins: iso to slightly hyperattenuating (high cellularity)\nirregular hypodense centre representing necrosis\nmarked mass effect\nsurrounding vasogenic oedema\nhaemorrhage is occasionally seen\ncalcification is uncommon\nintense irregular, heterogeneous enhancement of the margins is almost always present"], "MRIImageDescription": ["T1\nhypo to isointense mass within white matter\ncentral heterogeneous signal (necrosis, intratumoural haemorrhage)\nT1 C+ (Gd)\nenhancement is variable but is almost always present\ntypically peripheral and irregular with nodular components\nusually surrounds necrosis\nT2/FLAIR\nhyperintense\nsurrounded by vasogenic oedema\nflow voids are occasionally seen\nGE/SWI\nsusceptibility artefact on T2* from blood products (or occasionally calcification)\nLow-intensity rim from blood product 6\nincomplete and irregular in 85% when present\nmostly located inside the peripheral enhancing component\nabsent dual rim sign\nDWI/ADC\nsolid component\nelevated signal on DWI is common in solid/enhancing component\ndiffusion restriction is typically intermediate similar to normal white matter, but significantly elevated compared to surrounding vasogenic oedema (which has facilitated diffusion)\nADC values correlate with grade 13\nWHO IV (GBM) = 745 \u00b1 135 x 10-6 mm2/s\nWHO III (anaplastic) = 1067 \u00b1 276 x 10-6 mm2/s\nWHO II (low grade) = 1273 \u00b1 293 x 10-6 mm2/s\nADC threshold value of 1185 x 10-6 mm2/s sensitivity (97.6%) and specificity (53.1%) in the discrimination of high-grade (WHO grade III & IV) and low-grade (WHO grade II) gliomas 13\nnon-enhancing necrotic/cystic component\nthe vast majority (>90%) have facilitated diffusion (ADC values >1000 x 10-6 mm2/s)\ncare must be taken in interpreting cavities with blood product\nMR perfusion: rCBV elevated compared to lower grade tumours and normal brain\nMR spectroscopy\ntypical spectroscopic characteristics include\ncholine: increased\nlactate: increased\nlipids: increased\nNAA: decreased\nmyoiNOSitol: decreased"], "CTImageDescriptionInCN": ["\u5e73\u626b\uff1a\u597d\u53d1\u4e8e\u6df1\u90e8\u8111\u767d\u8d28,\u4ee5\u989d\u53f6\u3001\u989e\u53f6\u591a\u89c1,\u5e38\u4fb5\u72af\u90bb\u8fd1\u8111\u53f6\u3001\u7d2f\u53ca\u57fa\u5e95\u8282\u3001\u4e18\u8111,\u5e76\u53ef\u901a\u8fc7\u80fc\u80dd\u4f53\u4fb5\u72af\u5bf9\u4fa7\u5927\u8111\u534a\u7403,\u540e\u9885\u7a9d\u7f55\u89c1\u3002\u80bf\u7624\u751f\u957f\u8fc5\u901f\u591a\u5448\u4f4e\u5bc6\u5ea6\u6216\u4f4e\u3001\u7b49\u6df7\u6742\u5bc6\u5ea6\u7076\u3002\u5f62\u6001\u591a\u4e0d\u89c4\u5219,\u5c11\u6570\u5448\u5706\u5f62\u6216\u692d\u5706\u5f62\u3002\u8fb9\u7f18\u4e0d\u6574,\u8fb9\u754c\u4e0d\u6e05\u3002\u80bf\u7624\u8de8\u8d8a\u4e2d\u7ebf\u4fb5\u72af\u4e24\u4fa7\u5927\u8111\u534a\u7403\u65f6\u5448\u6240\u8c13\u8774\u8776\u72b6\u751f\u957f,\u5177\u6709\u4e00\u5b9a\u7684\u7279\u5f81\u6027,\u4f46\u4e5f\u53ef\u89c1\u4e8e\u5176\u4ed6\u80bf\u7624\u300295%\u7684\u75c5\u4f8b\u80bf\u7624\u4e2d\u5fc3\u5448\u4f4e\u5bc6\u5ea6,\u4e3a\u7624\u5185\u574f\u6b7b\u6216\u56ca\u53d8\u3002\u7624\u5185\u51fa\u8840\u5f88\u5e38\u89c1,\u9499\u5316\u5c11\u89c1,\u51fa\u73b0\u9499\u5316\u591a\u4ee3\u8868\u80bf\u7624\u662f\u7531\u4f4e\u5ea6\u661f\u5f62\u7ec6\u80de\u7624\u6076\u53d8\u800c\u6765\u3002\u80bf\u7624\u5468\u56f4\u6c34\u80bf\u548c\u5360\u4f4d\u8868\u73b0\u5e38\u8f83\u4e3a\u660e\u663e,\u4f7f\u4e2d\u7ebf\u7ed3\u6784\u79fb\u4f4d,\u90bb\u8fd1\u7684\u8111\u5ba4\u3001\u8111\u6c60\u53d7\u538b\u53d8\u5f62,\u53ef\u51fa\u73b0\u4e0d\u540c\u7a0b\u5ea6\u7684\u8111\u79ef\u6c34\u3002\u3000\u3000\n\n\u589e\u5f3a\uff1a\u80bf\u7624\u5b9e\u4f53\u90e8\u5206\u5f3a\u5316\u660e\u663e\u4f46\u4e0d\u5747\u4e00,\u5e38\u4e3a\u539a\u7684\u3001\u4e0d\u89c4\u5219\u7684\u8fb9\u7f18\u5f3a\u5316\u3002"], "DifferentialDiagnosisInCN": ["\u8868\u73b0\u4e3a\u7624\u7ec6\u80de\u79cd\u7c7b\u7684\u591a\u6837\u6027\u548c\u7624\u7ec6\u80de\u5f62\u6001\u7684\u591a\u5f62\u6027\u3002\u7624\u7ec6\u80de\u53ef\u5f02\u5e38\u5de8\u5927,\u4f46\u6570\u91cf\u8f83\u5c11;\u8840\u7ba1\u53ca\u5176\u5185\u76ae\u589e\u751f\u660e\u663e;\u7624\u5185\u5e38\u89c1\u574f\u6b7b\u800c\u5448\u7ea2\u8910\u8272, \u5176\u5468\u8fb9\u7624\u7ec6\u80de\u6838\u5448\u5047\u6805\u680f\u72b6\u6392\u5217\u3002\u955c\u4e0b,\u7ec6\u80de\u5bc6\u96c6,\u5f02\u578b\u6027\u660e\u663e,\u53ef\u89c1\u602a\u5f02\u7684\u5355\u6838\u6216\u591a\u6838\u7624\u5de8\u7ec6\u80de\u3002\u6bdb\u7ec6\u8840\u7ba1\u660e\u663e\u589e\u751f,\u5185\u76ae\u7ec6\u80de\u589e\u751f\u3001\u80bf\u5927,\u53ef\u5bfc\u81f4\u7ba1\u8154\u95ed\u585e\u548c\u8840\u6813\u5f62\u6210\u3002"], "MRIImageDescriptionInCN": ["\u5e73\u626b\uff1aT1WI \u80bf\u7624\u5b9e\u4f53\u90e8\u5206\u5448\u7b49\u6216\u4f4e\u3001\u7b49\u6df7\u6742\u4fe1\u53f7,\u4e0e\u80bf\u7624\u5468\u56f4\u6c34\u80bf\u7684\u4f4e\u4fe1\u53f7\u5f80\u5f80\u4e0d\u80fd\u533a\u5206\u3002\u574f\u6b7b\u548c\u56ca\u53d8\u4e5f\u5448\u4f4e\u4fe1\u53f7,\u5176\u4fe1\u53f7\u5f3a\u5ea6\u5e38\u4f4e\u4e8e\u80bf\u7624\u5b9e\u4f53\u90e8\u5206\u3002T2WI \u663e\u793a\u80bf\u7624\u53ca\u5176\u76f8\u5173\u53d8\u5316\u4f18\u4e8eT1WI,\u80bf\u7624\u5b9e\u4f53\u90e8\u5206\u5448\u9ad8\u6216\u9ad8\u3001\u7b49\u6df7\u6742\u4fe1\u53f7\u3002\u574f\u6b7b\u548c\u56ca\u53d8\u5448\u9ad8\u4fe1\u53f7,\u80bf\u7624\u5468\u56f4\u6c34\u80bf\u4e5f\u5448\u9ad8\u4fe1\u53f7\u3002\u4e9a\u6025\u6027\u51fa\u8840\u5728T1WI\u548cT2WI \u5747\u5448\u9ad8\u4fe1\u53f7\u3002\n\n\u589e\u5f3a\uff1a\u5448\u4e0d\u89c4\u5219\u7684\u8fb9\u7f18\u73af\u72b6\u5f3a\u5316,\u5b9e\u4f53\u90e8\u5206\u5f3a\u5316\u660e\u663e,\u56ca\u53d8\u574f\u6b7b\u533a\u53ca\u80bf\u7624\u5468\u56f4\u6c34\u80bf\u5747\u65e0\u5f3a\u5316\u3002\u503c\u5f97\u6ce8\u610f\u7684\u662f\u80bf\u7624\u7684\u5b9e\u9645\u6d78\u6da6\u8303\u56f4\u5e38\u8d85\u8fc7\u5f3a\u5316\u7684\u8303\u56f4,\u955c\u68c0\u53d1\u73b0\u5728\u5f3a\u5316\u8fb9\u7f18\u4ee5\u5916\u5e38\u53ef\u89c1\u80bf\u7624\u7ec6\u80de\u6d78\u6da6,\u591a\u6570\u5728\u5f3a\u5316\u8fb9\u7f18\u4ee5\u59162cm\u4e4b\u5185,\u4e5f\u53ef\u8fdc\u8fbe3.5cm\u3002MRI\u5bf9\u6bd4\u5242\uff08Gd-DTPA\uff09\u7684\u5e38\u89c4\u5242\u91cf\u4e3a0.1mmol/Kg,\u589e\u5927\u5bf9\u6bd4\u5242\u7684\u5242\u91cf\uff080.2~0.3mmol/Kg\uff09\u53ef\u4f7f\u80bf\u7624\u7684\u5f3a\u5316\u8303\u56f4\u6269\u5927,\u66f4\u63a5\u8fd1\u80bf\u7624\u7684\u5b9e\u9645\u4e0a\u5927\u5c0f,\u8fd9\u6837\u53ef\u4ee5\u66f4\u51c6\u786e\u7684\u4f30\u8ba1\u80bf\u7624\u7684\u6d78\u6da6\u8303\u56f4\u3002"], "PathogenyInCN": ["\u5927\u591a\u6570\u75c5\u4f8b\u7684\u539f\u56e0\u5c1a\u4e0d\u6e05\u695a\u3002\u7ea65\uff05\u53d1\u5c55\u4e3a\u53e6\u4e00\u79cd\u7c7b\u578b\u7684\u8111\u7624,\u79f0\u4e3a\u4f4e\u7ea7\u661f\u5f62\u7ec6\u80de\u7624\u3002\u5176\u4ed6\u76f8\u5173\u75be\u75c5\u5305\u62ec\u5438\u70df,\u519c\u836f\u66b4\u9732,\u77f3\u6cb9\u7cbe\u70bc\u6216\u6a61\u80f6\u5236\u9020\u7b49\u3002\u80f6\u8d28\u6bcd\u7ec6\u80de\u7624\u4e0e\u75c5\u6bd2\u6709\u5173 SV40,HHV-6\u548c\u5de8\u7ec6\u80de\u75c5\u6bd2\u3002"], "areas": {"corpusCallosum": [{"name": "\u80da\u80ce\u6027\u80bf\u7624\u4f34\u591a\u5c42\u83ca\u5f62\u56e2,C19MC\u53d8\u5f02", "id": "tumor_child_26"}, {"name": "\u6dcb\u5df4\u7ec6\u80de\u4e30\u5bcc\u578b\u8111\u819c\u7624", "id": "tumor_child_80"}, {"name": "\u4e73\u5934\u578b\u8111\u819c\u7624", "id": "tumor_child_82"}, {"name": "\u5206\u6ccc\u578b\u8111\u819c\u7624", "id": "tumor_child_86"}, {"name": "\u8102\u80aa\u7624", "id": "tumor_child_95"}, {"name": "\u8840\u7ba1\u6bcd\u7ec6\u80de\u7624", "id": "tumor_child_100"}, {"name": "\u8840\u7ba1\u8089\u7624", "id": "tumor_child_110"}, {"name": "\u6a2a\u7eb9\u808c\u7624", "id": "tumor_child_116"}, {"name": "\u6a2a\u7eb9\u808c\u8089\u7624", "id": "tumor_child_117"}, {"name": "\u5e73\u6ed1\u808c\u8089\u7624", "id": "tumor_child_120"}, {"name": "\u708e\u75c7\u6027\u808c\u7ea4\u7ef4\u6bcd\u7ec6\u80de\u7624", "id": "tumor_child_123"}, {"name": "\u4e73\u5934\u72b6\u80f6\u8d28\u795e\u7ecf\u5143\u80bf\u7624", "id": "tumor_child_128"}, {"name": "\u8111\u5ba4\u5916\u795e\u7ecf\u7ec6\u80de\u7624", "id": "tumor_child_129"}, {"name": "\u795e\u7ecf\u8282\u7ec6\u80de\u7624", "id": "tumor_child_130"}, {"name": "\u591a\u5f62\u6027\u9ec4\u8272\u661f\u5f62\u7ec6\u80de\u7624", "id": "tumor_child_137"}, {"name": "\u6076\u6027\u5468\u56f4\u795e\u7ecf\u9798\u7624\uff08MPNST\uff09", "id": "tumor_child_151"}], "meningealLayers": [{"name": "\u5de8\u7ec6\u80de\u578b\u80f6\u8d28\u6bcd\u7ec6\u80de\u7624", "id": "tumor_child_17"}, {"name": "\u80da\u80ce\u6027\u80bf\u7624\u4f34\u591a\u5c42\u83ca\u5f62\u56e2,C19MC\u53d8\u5f02", "id": "tumor_child_26"}, {"name": "\u6dcb\u5df4\u7ec6\u80de\u4e30\u5bcc\u578b\u8111\u819c\u7624", "id": "tumor_child_80"}, {"name": "\u4e73\u5934\u578b\u8111\u819c\u7624", "id": "tumor_child_82"}, {"name": "\u5206\u6ccc\u578b\u8111\u819c\u7624", "id": "tumor_child_86"}, {"name": "\u8102\u80aa\u7624", "id": "tumor_child_95"}, {"name": "\u8840\u7ba1\u6bcd\u7ec6\u80de\u7624", "id": "tumor_child_100"}, {"name": "\u8840\u7ba1\u8089\u7624", "id": "tumor_child_110"}, {"name": "\u6a2a\u7eb9\u808c\u7624", "id": "tumor_child_116"}, {"name": "\u6a2a\u7eb9\u808c\u8089\u7624", "id": "tumor_child_117"}, {"name": "\u5e73\u6ed1\u808c\u8089\u7624", "id": "tumor_child_120"}, {"name": "\u708e\u75c7\u6027\u808c\u7ea4\u7ef4\u6bcd\u7ec6\u80de\u7624", "id": "tumor_child_123"}, {"name": "\u4e73\u5934\u72b6\u80f6\u8d28\u795e\u7ecf\u5143\u80bf\u7624", "id": "tumor_child_128"}, {"name": "\u8111\u5ba4\u5916\u795e\u7ecf\u7ec6\u80de\u7624", "id": "tumor_child_129"}, {"name": "\u795e\u7ecf\u8282\u7ec6\u80de\u7624", "id": "tumor_child_130"}, {"name": "\u591a\u5f62\u6027\u9ec4\u8272\u661f\u5f62\u7ec6\u80de\u7624", "id": "tumor_child_137"}, {"name": "\u6076\u6027\u5468\u56f4\u795e\u7ecf\u9798\u7624\uff08MPNST\uff09", "id": "tumor_child_151"}]}}, "pics": {"d29": ["A small subcortical region of high T2 signal is seen in the left frontal lobe.", "\u5728\u5de6\u989d\u53f6\u4e2d\u53ef\u89c1\u4e00\u4e2a\u9ad8T2\u4fe1\u53f7\u7684\u5c0f\u76ae\u5c42\u4e0b\u533a\u3002"], "d26": ["Large tumour centred in the body of the corpus Callosum with heterogenous and multifocal areas of enhancement and imaging appearances typical for glioblastoma.", "\u5927\u80bf\u7624\u96c6\u4e2d\u5728\u80fc\u80dd\u4f53\u7684\u4f53\u5185\uff0c\u80fc\u80dd\u4f53\u4e0e\u5f02\u8d28\u6027\u548c\u591a\u7126\u70b9\u533a\u57df\u7684\u589e\u5f3a\u548c\u5f71\u50cf\u5b66\u8868\u73b0\u5178\u578b\u7684\u80f6\u8d28\u6bcd\u7ec6\u80de\u7624\u3002"], "d27": ["A VP shunt is in situ, and a left-sided subdural collection is present. Near the foramen of Munro, a mass with heterogeneous hyperdensity is present.", "\u4e00\u4e2a\u526f\u5206\u6d41\u5668\u5728\u539f\u4f4d\uff0c\u5e76\u4e14\u6709\u4e00\u4e2a\u5de6\u8fb9\u7684\u786c\u819c\u6536\u96c6\u3002\u5728\u95e8\u7f57\u7684\u5b54\u9644\u8fd1\uff0c\u5b58\u5728\u7740\u4e00\u4e2a\u975e\u5747\u5300\u9ad8\u5bc6\u5ea6\u7684\u7269\u8d28\u3002"], "d30": ["A peripherally enhancing lesion is located within the left frontal lobe. ", "\u8fb9\u7f18\u589e\u5f3a\u75c5\u53d8\u4f4d\u4e8e\u5de6\u989d\u53f6\u5185\u3002"], "d28": ["A well-circumscribed mass in the region of the foramen of Munro is present with central intrinsic high T1 signal and layering low T2 signal consistent with haemorrhage. It is well circumscribed.High T2 signal within the corpus Callosum likely represents the sequela of hydrocephalus and compression against the falx rather than tumour infiltration. A right sided shunt is in situ. No subependymal nodules of parenchymal changes to suggest underlying tuberous sclerosis.", "\u5728\u95e8\u7f57\u7684\u5b54\u533a\u57df\u5185\uff0c\u6709\u4e00\u4e2a\u53d7\u5230\u826f\u597d\u9650\u5236\u7684\u8d28\u91cf\uff0c\u5b83\u5177\u6709\u4e2d\u592e\u56fa\u6709\u7684\u9ad8T1\u4fe1\u53f7\u548c\u4e0e\u51fa\u8840\u4e00\u81f4\u7684\u4f4eT2\u4fe1\u53f7\u3002\u9650\u5236\u3002\u80fc\u80dd\u4f53\u5185\u7684\u9ad8T2\u4fe1\u53f7\u5f88\u53ef\u80fd\u4ee3\u8868\u8111\u79ef\u6c34\u7684\u540e\u9057\u75c7\uff0c\u800c\u4e0d\u662f\u80bf\u7624\u6d78\u6da6\u800c\u538b\u8feb\u9570\u72b6\u7ec6\u80de\u3002\u53f3\u8fb9\u7684\u5206\u6d41\u5668\u5728\u539f\u4f4d\u3002\u65e0\u5ba4\u7ba1\u819c\u4e0b\u7ed3\u8282\u7684\u5b9e\u8d28\u6539\u53d8\u63d0\u793a\u6f5c\u5728\u7ed3\u8282\u6027\u786c\u5316\u75c7\u3002"]}}